ABSTRACT: Dr. Kleanthi Dima will provide an overview - from the European perspective - of the opportunities that POCT can provide while identifying the limitations to be considered when choosing whether to implement POCT or not, the clinically relevant analytical techniques, the current technologies, clinical applications, networking and quality issues, and regulatory aspects. In addition, latest technologies, e.g., novel POCT applications of molecular testing for the rapid identification of infectious agents as well as for non-pathogen-related problems will be presented. Another new area of POCT includes the companion diagnostics which help with the appropriate treatment choice, the continuous measurement of metabolites such as continuous transdermal glucose testing, and the Wearables. Finally, a short review of POCT for COVID 19 will close the presentation.
|